Marbocyl SA 200mg: Contra-indications, warnings, etc
|
Marbocyl SA 200mg
Contra-indications, warnings, etc
Marbofloxacin should not be used in dogs aged less than 12 months or less than 18 months for exceptionally large breeds of dogs, such as Great Danes or Mastiffs with a longer growth period.
Studies carried out with laboratory animals showed no embryotoxic, foetotoxic or teratogenic effects. However, no specific studies have been carried out on pregnant cats or dogs.
The dosage of theophylline must be reduced when used concurrently.
Overdosage may cause acute signs in the form of neurological disorders, hypersalivation or trembling which should be treated symptomatically.
After subcutaneous administration, no undesirable effect is observed up to 2 times the maximum recommended therapeutic dose in dogs or 3 times the maximum recommended dose for cats. After i.v. administration at 4mg/kg, rare mild and transitory side effects have been reported: -ptyalism (excess salivation) - nervous disorders: vocalization, excitation, trembling (myoclonia).
Withdrawal period
Not applicable
Operator warning
People with known hypersensitivity to fluoroquinolones should avoid using this product. Wash hands after use.
|
 |
 
        |
 |
|
|
|
|||||||||||||||||||||||||
Date updated: 30 November 2007